1,263
Views
19
CrossRef citations to date
0
Altmetric
Original Article

Efficacy of exclusive enteral nutrition in complicated Crohn’s disease

, , , , , , & show all
Pages 995-1001 | Received 17 Mar 2017, Accepted 24 May 2017, Published online: 09 Jun 2017
 

Abstract

Aim: To investigate the efficacy of exclusive enteral nutrition (EEN) in induction of remission in adult active Crohn’s disease (CD) complicated with intestinal fistula/abdominal abscess or inflammatory intestinal stricture.

Method: Patients diagnosed with active CD with complications were recruited between July 2013 and July 2015. Patients were offered EEN for 12 weeks. Patients with abscess received antibiotic treatment with or without percutaneous drainage. Clinical variables were recorded (ClinicalTrials.gov Identifier: NCT02887287).

Results: Forty-one patients with CD and with intestinal fistula/abdominal abscess or inflammatory intestinal stricture aged 18–60 years, were included. Ten patients were accompanied with stenosis and 33 with intestinal fistula/abscess. After 12 weeks of EEN, the Crohn's disease activity index significantly decreased (223.43 ± 65.5 vs. 106.77 ± 42.73, p ≤ .001), and 80.5% of patients achieved full clinical remission totally. Fistula closure after EEN was observed in 75% of patients with entero-cutaneous fistula. In patients with stenosis, 20% had no response to EEN and were transferred for surgery. Partial remission and full remission were observed in 20% and 60% of patients after 12 weeks of EEN, respectively. Intra-abdominal abscess resolved in 76% of patients. Seventeen patients who had mucosal ulcers underwent colonoscopy before and after EEN, 47% achieved mucosal healing after the treatment. The inflammatory index of patients significantly decreased (p ≤ .01), nutritional parameters increased (p ≤ .01) and the European Nutritional Risk Screening (2002) decreased (p ≤ .01).

Conclusion: EEN is effective in inducing early clinical remission, mucosal healing, promoting fistula closure and reducing the size of abscess in adult CD patients with complications.

Disclosure statement

To the best of our knowledge, no conflict of interest, financial or other, exists.

Additional information

Funding

This work was supported by National Key Clinical Discipline, the National Natural Science Foundation of China (No. 81370498), Science and Technology Department, Guangdong Province, China (No. 2012B091100455), and Science and Technology Project of Tianhe District, Guangdong Province, China (No.201404KW018).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.